Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

10x Genomics, Inc. (TXG)

$72.96 +1.97% NASDAQ: TXG · 15-min delayed
  • PLEASANTON, California
  • Public · NASDAQ: TXG
  • 1,178 employees
$5.9BMarket cap
$642.8MRevenue · FY2025
-$43.5MNet income
1,178Employees
TXGNASDAQ
2019IPO

About 10x Genomics, Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$642.8M
Net income
-$43.5M
Total assets
$1.0B
Market cap
$5.9B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: TXG
$72.96 +1.97%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$11.34 $97.74

52-week range

Market cap
$5.9B
Shares outstanding
80.5M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Sep 12, 2019

10x Genomics, Inc. (TXG) Stock Price

  • Reported a net loss of $43.5M in FY2025.
  • Trading 25% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review 10x Genomics, Inc..

Write a review
Newsroom

News about 10x Genomics, Inc.

News & sentiment via Polygon.io

FAQ

10x Genomics, Inc.: frequently asked questions

Is 10x Genomics, Inc. an American company?

10x Genomics, Inc. is a US-based company headquartered in Pleasanton, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is 10x Genomics, Inc. headquartered?

10x Genomics, Inc. is headquartered in Pleasanton, California, United States.

Is 10x Genomics, Inc. publicly traded?

Yes — 10x Genomics, Inc. is a publicly traded company. Its stock trades under the ticker symbol TXG on the NASDAQ.

What does 10x Genomics, Inc. do?

10x Genomics, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →